Daisuke Okuzaki Selected Research

Neoplasm Metastasis (Metastasis)

12/2021	Mitochondrial matrix protein C14orf159 attenuates colorectal cancer metastasis by suppressing Wnt/β-catenin signalling.
11/2021	The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway.
9/2021	Chk1 suppression leads to a reduction in the enhanced radiation-induced invasive capability on breast cancer cells.
12/2016	Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daisuke Okuzaki Research Topics

Disease

41	Neoplasms (Cancer) 01/2022 - 06/2007
9	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 12/2014
7	Inflammation (Inflammations) 04/2022 - 01/2017
7	Infections 01/2021 - 08/2012
7	Colonic Neoplasms (Colon Cancer) 01/2020 - 01/2013
5	Colitis 01/2021 - 06/2014
4	Neoplasm Metastasis (Metastasis) 12/2021 - 12/2016
4	Dyslipidemias (Dyslipidemia) 01/2020 - 01/2016
3	Sepsis (Septicemia) 01/2022 - 01/2021
3	Hypoxia (Hypoxemia) 12/2021 - 04/2016
3	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2020
3	Starvation 01/2021 - 10/2016
3	Alcoholic Fatty Liver 01/2020 - 01/2018
3	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2014
3	Non-alcoholic Fatty Liver Disease 11/2018 - 01/2016
2	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2018
2	Fibrosis (Cirrhosis) 01/2022 - 01/2022
2	COVID-19 01/2022 - 01/2021
2	Endometrioid Carcinoma 12/2021 - 05/2019
2	Glioma (Gliomas) 11/2021 - 01/2020
2	Hypertriglyceridemia 11/2021 - 01/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 01/2020
2	Rhinosinusitis 01/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2016
2	Obesity 01/2020 - 01/2016
2	Rheumatoid Arthritis 12/2019 - 10/2019
2	Stroke (Strokes) 01/2019 - 09/2015
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 01/2016
2	Necrosis 01/2018 - 01/2015
2	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 01/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2016 - 03/2010
2	Autoimmune Diseases (Autoimmune Disease) 09/2015 - 08/2008
2	Osteosarcoma (Osteogenic Sarcoma) 04/2014 - 01/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2014 - 05/2013
2	Vasculitis (Vasculitides) 09/2013 - 08/2008
2	Tonsillitis 01/2011 - 03/2010
1	Fragile X Syndrome (Martin Bell Syndrome) 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Fatty Liver 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
13	MicroRNAs (MicroRNA)IBA 02/2020 - 08/2012
6	Messenger RNA (mRNA)IBA 11/2019 - 08/2006
5	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2017
5	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2021 - 06/2014
5	Dextrans (Dextran)FDA Link 01/2021 - 06/2014
4	Interleukin-18 (Interleukin 18)IBA 01/2020 - 01/2016
3	CytokinesIBA 01/2022 - 01/2021
3	AntigensIBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 11/2021 - 10/2019
3	Adenosine Triphosphate (ATP)IBA 08/2021 - 01/2021
3	VaccinesIBA 01/2021 - 11/2018
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2014
3	Pharmaceutical PreparationsIBA 05/2020 - 01/2016
3	Dinoprostone (PGE2)FDA Link 01/2020 - 04/2016
2	Chemokine ReceptorsIBA 01/2022 - 08/2006
2	NivolumabIBA 01/2022 - 10/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2018
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 11/2018
2	CholesterolIBA 01/2022 - 01/2020
2	InterleukinsIBA 11/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2021
2	Long Noncoding RNAIBA 11/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 08/2021 - 03/2010
2	Parathyroid Hormone (Parathormone)IBA 01/2021 - 04/2016
2	CSK Tyrosine-Protein KinaseIBA 02/2020 - 07/2018
2	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 11/2019
2	InterferonsIBA 12/2019 - 09/2013
2	Amino Acids FDA Link 11/2019 - 10/2016
2	IntegrinsIBA 11/2019 - 01/2016
2	LigandsIBA 11/2019 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 08/2008
2	Dextran SulfateIBA 09/2018 - 01/2017
2	PaxillinIBA 07/2018 - 01/2016
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 09/2015
2	Genetic Markers (Genetic Marker)IBA 01/2016 - 08/2008
2	AngiotensinogenIBA 09/2015 - 04/2014
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2015 - 04/2014
2	Phosphotransferases (Kinase)IBA 01/2014 - 06/2007
1	Indomethacin (Indometacin)FDA LinkGeneric 04/2022
1	2- amino- 4- ((3- (carboxymethyl)phenyl)(methyl)phosphono)butanoic acidIBA 01/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA 01/2022
1	JTE 013IBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022

Therapy/Procedure

11	Therapeutics 11/2021 - 03/2010
4	Immunotherapy 01/2022 - 01/2018
3	Drug Therapy (Chemotherapy) 01/2022 - 03/2015
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Radiotherapy 11/2021 - 09/2021
2	Subcutaneous Injections 09/2018 - 01/2013
2	Intravenous Administration 01/2018 - 01/2016
2	Tonsillectomy 01/2011 - 03/2010
1	Electrodes (Electrode) 01/2022
1	Ligation 01/2022